Workflow
Performance Services
icon
Search documents
Apogee(APOG) - 2026 Q2 - Earnings Call Transcript
2025-10-10 14:02
Financial Data and Key Metrics Changes - Net sales increased by 4.6% to $358.2 million, driven by $24.9 million of inorganic sales from the acquisition of UW Solutions [8][10] - Adjusted EBITDA margin decreased to 12.4%, primarily due to lower price and volume, unfavorable mix, and higher material, tariff, and health insurance costs [8][10] - Adjusted diluted EPS declined to $0.98, mainly driven by lower adjusted EBITDA and higher interest expense [8][10] Business Line Data and Key Metrics Changes - Performance Services net sales increased by 18.6% organically, primarily from improved retail channel distribution [9] - Metals segment net sales declined slightly, reflecting a less favorable mix, despite higher volume and price [9] - Glass segment net sales declined, with adjusted EBITDA margin moderating due to reduced volume and price from lower end-market demand [9][10] Market Data and Key Metrics Changes - The competitive environment for glass has not improved, leading to lower expectations for glass volume and price [4][10] - Aluminum costs increased by approximately 20% during the second quarter, impacting pricing and volume in the Metals segment [14][36] Company Strategy and Development Direction - The company is focused on driving year-over-year net sales and adjusted EPS growth, primarily through Performance Services [5][16] - Strategic actions include tariff mitigation efforts and Project Fortify II to enhance organizational agility [7][16] - The company is actively pursuing M&A opportunities that align with strategic and financial objectives [7][16] Management's Comments on Operating Environment and Future Outlook - Management expressed disappointment over lowered expectations but remains optimistic about year-over-year growth in the second half of the fiscal year [5][15] - The company anticipates challenges in glass and metals due to competitive pricing pressures and rising aluminum costs [14][36] - Despite macroeconomic challenges, management is confident in the company's strong cash flow and balance sheet for future success [15][16] Other Important Information - The updated outlook for fiscal 2026 includes net sales in the range of $1.39 billion to $1.42 billion and adjusted diluted EPS in the range of $3.60 to $3.90 [10][11] - The One Big Beautiful Bill Act is expected to provide a cash tax benefit primarily impacting fiscal 2026 [11] Q&A Session Summary Question: Can you expand on the organic growth in Performance Services? - Management noted strong growth in UW Solutions, particularly due to regained distribution and cross-selling opportunities [21][23] Question: What is driving the increase in services backlog? - The backlog growth was attributed to projects in the Northeast and efforts to expand into new markets [25][26] Question: What are the expectations for the glass segment's margins? - Management expects mid-teens EBITDA margins for the glass segment despite competitive pressures [32][33] Question: How is the metals segment impacted by cost pressures? - The increase in aluminum costs is the main driver of pressure in the metals segment, affecting pricing and volume [36][39] Question: What is the outlook for Performance Services' flooring mix? - The flooring segment is expected to grow and now represents over half of the UW portfolio [41]
Here's What Key Metrics Tell Us About Premier (PINC) Q4 Earnings
ZACKS· 2025-08-19 14:31
Core Insights - Premier, Inc. reported a revenue of $262.86 million for the quarter ended June 2025, which is a 25% decrease compared to the same period last year, while EPS was $0.46, down from $0.69 year-over-year [1] - The reported revenue exceeded the Zacks Consensus Estimate of $242.42 million by 8.43%, and the EPS also surpassed the consensus estimate of $0.34 by 35.29% [1] Financial Performance Metrics - Net Revenue from Supply Chain Services for Software licenses and other services was $19.95 million, exceeding the average estimate of $17.24 million [4] - Net Revenue from Performance Services was $92.86 million, compared to the average estimate of $87.13 million, representing a year-over-year decline of 22.9% [4] - Total Net Revenue from Supply Chain Services was $170 million, surpassing the estimated $155.56 million, but reflecting a 26.1% decrease from the previous year [4] - Net administrative fees from Supply Chain Services were reported at $150.05 million, above the average estimate of $138.33 million, with a year-over-year change of -9.3% [4] - Adjusted EBITDA for Supply Chain Services was $89.99 million, exceeding the average estimate of $81.52 million [4] - Adjusted EBITDA for Performance Services was $17.17 million, compared to the average estimate of $15.87 million [4] - Corporate Adjusted EBITDA was reported at -$38.3 million, worse than the average estimate of -$33.22 million [4] Stock Performance - Shares of Premier have returned +16.7% over the past month, outperforming the Zacks S&P 500 composite's +2.5% change [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating potential performance in line with the broader market in the near term [3]
Premier(PINC) - 2025 Q4 - Earnings Call Transcript
2025-08-19 13:02
Financial Data and Key Metrics Changes - Total full year revenue reached $986 million, exceeding guidance by $11 million, while adjusted EPS was $1.54, surpassing the high end of guidance by $0.11 [14][15] - Fourth quarter net revenue was $258 million, a 1% increase sequentially but a decline from the prior year due to higher fee share from contract renewals [14][15] - GAAP net income was $18 million or $0.22 per share, down from the prior year mainly due to lower revenue [15] - Adjusted EBITDA for the fourth quarter was $71 million, flat sequentially, with a margin of 27.6% [15] Business Line Data and Key Metrics Changes - Supply Chain Services segment performed above expectations, with gross administrative fees growing over 3% in fiscal year 2025, driven by higher contract penetration and onboarding of new members [16][17] - Performance Services segment showed sequential improvement in advisory business, although it was lower compared to the prior year due to rebuilding the sales funnel [18] - Other supply chain services revenue grew by 17% in the co-management business and 15% in the digital supply chain business [17] Market Data and Key Metrics Changes - The company noted increasing demand for margin improvement solutions among member hospitals due to ongoing cost pressures and reimbursement uncertainty [11][12] - The acquisition of Illumicare is expected to enhance the company's ability to deliver real-time insights and expand its addressable market [10][49] Company Strategy and Development Direction - The company is focused on helping health systems transition from short-term cost containment to structural changes that enhance operational resilience [8][9] - The acquisition of Illumicare is part of a strategy to strengthen clinical decision support capabilities and leverage AI for better healthcare outcomes [10][49] - The company anticipates returning to positive growth in total net revenue, adjusted EBITDA, and adjusted EPS in fiscal year 2027 [22][24] Management Comments on Operating Environment and Future Outlook - Management highlighted ongoing financial pressures for member hospitals and the need for value-based strategic support [7][8] - The company expects fiscal year 2026 to be a year of stabilization and transition, with a return to growth anticipated in fiscal year 2027 [21][22] - Management expressed confidence in the ability to drive growth due to the strength of the business and the commitment of the team [12][24] Other Important Information - Free cash flow for fiscal year 2025 was $181 million, with a conversion rate of 69%, and is expected to be in the range of 70% to 80% for fiscal year 2026 [19][20] - The company completed a $200 million accelerated share repurchase program, bringing total repurchases to $800 million under a $1 billion authorization [15][20] Q&A Session Summary Question: Changes in customer buying behavior in Supply Chain Services - Management noted no significant pull forward in buying behavior due to tariffs, with some increases attributed to regional issues [26][27] Question: Momentum in the advisory business - The advisory business is driven by market dynamics and the expertise of the newly hired leadership, with recent large engagements contributing to growth [28][30] Question: Cadence of admin fee renewal and growth assumptions - Management expects fee share to increase to the mid-60% range in fiscal year 2026, with broad-based growth across key categories [36][38] Question: Size and impact of Illumicare acquisition - Illumicare is projected to generate $8 million to $10 million in revenue for fiscal year 2026, with breakeven EBITDA [49][50] Question: Advisory business growth visibility - Advisory business is expected to grow above 25% in fiscal year 2026, largely driven by recent large contracts [61][62] Question: Free cash flow guidance and TRA impact - The TRA benefit is included in free cash flow guidance, with expectations for improved cash flow in fiscal year 2026 [66][67] Question: Demand for technology post July 4 - There remains strong interest in clinical decision support capabilities, with technology driving demand for performance improvement [93][97] Question: Unique advisory contracts and differences from consulting - Advisory engagements focus on comprehensive performance improvement strategies, with consulting and advisory viewed as interchangeable terms [104][106] Question: Life sciences or pharma support business updates - The life sciences business is performing as expected, with growth opportunities anticipated moving forward [107][108]
Premier(PINC) - 2025 Q4 - Earnings Call Transcript
2025-08-19 13:00
Financial Data and Key Metrics Changes - Total full year revenue reached $986 million, exceeding guidance by $11 million, while adjusted EPS was $1.54, surpassing the high end of guidance by $0.11 [13][14] - Fourth quarter net revenue was $258 million, a 1% increase sequentially but a decline from the prior year due to higher fee share from contract renewals [13][14] - Adjusted EBITDA for the fourth quarter was $71 million, translating to a margin of 27.6%, benefiting from revenue outperformance in Supply Chain Services [14] Business Line Data and Key Metrics Changes - Supply Chain Services segment performed above expectations, with gross administrative fees growing over 3% in fiscal year 2025, driven by higher contract penetration and onboarding of new members [15][16] - Performance Services segment showed sequential improvement in advisory business, although it was lower compared to the prior year as the sales funnel is being rebuilt [17] - Other supply chain services revenue grew by 17% in the co-management business and 15% in the digital supply chain business, indicating growth opportunities for fiscal year 2026 and beyond [16][17] Market Data and Key Metrics Changes - The company noted increasing financial pressures on member hospitals and health systems, leading to a demand for value-based strategic support [6][10] - The acquisition of Illumicare is expected to enhance the company's ability to deliver real-time insights and expand its addressable market [8][20] Company Strategy and Development Direction - The company is focused on helping health systems transition from short-term cost containment to structural changes that enhance operational resilience [6][10] - The acquisition of Illumicare is part of a strategy to strengthen clinical decision support capabilities and leverage AI for better healthcare outcomes [8][20] - The company anticipates a stabilization year in fiscal year 2026, with a return to growth in key financial metrics expected in fiscal year 2027 [21][23] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to drive growth, citing a robust pipeline of advisory business and strategic engagements [7][11] - The company expects free cash flow conversion in fiscal year 2026 to be in the range of 70% to 80%, with a cash tax rate anticipated to be less than 5% over the next five years [18][19] - Management highlighted the importance of addressing contract renewals and the anticipated increase in fee share to the mid-60% range in fiscal year 2026 [16][36] Other Important Information - The company completed a $200 million accelerated share repurchase program, bringing total stock repurchases to $800 million under a $1 billion authorization [14][19] - The company is winding down the Contigo Health assets, with expected revenue of $9 million and an EBITDA loss of $6 million in fiscal year 2026 [49] Q&A Session Summary Question: Changes in customer buying behavior in Supply Chain Services - Management noted no significant pull forward in buying behavior due to tariffs, with some regional increases observed [25] Question: Momentum in the advisory business - The advisory business is driven by market dynamics and the expertise of the newly hired leadership, with significant recent contract wins [26][30] Question: Cadence of admin fee renewal and growth assumptions - Management expects a gradual increase in fee share throughout fiscal year 2026, with gross administrative fees anticipated to grow around 4% [35][36] Question: Size and impact of Illumicare acquisition - Illumicare is projected to generate $8 million to $10 million in revenue for fiscal year 2026, breakeven on EBITDA, and is expected to drive future growth [48] Question: Advisory business size and growth visibility - The advisory business is estimated to be between $50 million to $100 million, with expectations of over 25% growth in fiscal year 2026 driven by recent large contracts [58][60] Question: Free cash flow guidance and TRA impact - The TRA benefit is included in free cash flow guidance, with expectations for improved cash flow in fiscal year 2026 due to the absence of the $100 million headwind [64][66] Question: Demand changes post July 4 and SaaS offerings - There remains significant interest in clinical decision support capabilities, with ongoing demand for technology that drives performance improvement [90][92]
Countdown to Premier (PINC) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS
ZACKS· 2025-08-14 14:16
Group 1 - Analysts expect Premier, Inc. (PINC) to report quarterly earnings of $0.34 per share, reflecting a year-over-year decline of 50.7% [1] - Revenue is anticipated to be $242.42 million, down 30.8% from the same quarter last year [1] - There have been no revisions in the consensus EPS estimate over the last 30 days, indicating stability in analysts' forecasts [1] Group 2 - Analysts project 'Net Revenue- Performance Services' to reach $87.13 million, a decrease of 27.6% from the previous year [4] - 'Net Revenue- Total Supply Chain Services' is expected to be $155.56 million, down 32.4% year-over-year [4] - The estimate for 'Net Revenue- Supply Chain Services- Net administrative fees' is $138.33 million, indicating a year-over-year change of -16.4% [5] Group 3 - The consensus estimate for 'Adjusted EBITDA- Supply Chain Services' is $81.52 million, compared to $123.45 million in the same quarter last year [5] - 'Adjusted EBITDA- Performance Services' is projected to be $15.87 million, down from $33.67 million in the same quarter last year [6] - Over the past month, shares of Premier have increased by 16.8%, outperforming the Zacks S&P 500 composite's 3.5% change [6]
Premier (PINC) 2025 Conference Transcript
2025-05-13 17:20
Summary of Premier (PINC) 2025 Conference Call Company Overview - **Company**: Premier Inc. (PINC) - **Date of Conference**: May 13, 2025 - **Speakers**: Mike Alkire (President and CEO), Glenn Coleman (Chief Administrative and Financial Officer) Key Industry Insights - **Healthcare Provider Challenges**: The healthcare sector is facing significant labor shortages, particularly in nursing and essential technical roles, exacerbated by resignations during COVID-19 [3][4] - **Impact of Tariffs**: Hospitals are anticipating a 6% to 7% increase in costs due to tariffs, which they cannot absorb given their operating margins [9][10] - **Medicaid Cuts**: Potential Medicaid cuts could have an $80 billion impact on healthcare systems, necessitating structural realignment within these organizations [4][5] Company Positioning and Strategy - **Technological Investments**: Premier has invested in technology to assist healthcare systems in performance improvement, cost management, and operational efficiency [5][6] - **Integration with Workflows**: The company has developed capabilities to integrate its services into the workflows of healthcare providers, enhancing patient treatment processes [6][8] - **Tariff Management Tools**: Premier has created tools to help members understand the sourcing of products and the impact of tariffs, providing options to mitigate costs [7][11] Financial Performance and Projections - **Supply Chain Services Growth**: The supply chain services segment has shown a 3.5% growth year-to-date, with significant opportunities for further contract penetration [24][26] - **Fee Structure**: The aggregate blended fee share is expected to rise from the low 60s to the high 60s by the end of fiscal year 2026 [23] - **Performance Services**: The performance services segment has outperformed expectations, particularly in enterprise licenses, indicating strong momentum [48][49] Competitive Landscape - **Market Competition**: The environment remains competitive, with several key players in the industry. Premier differentiates itself through technology and data access, leveraging insights from 45% of all hospital discharges in the U.S. [33][36] - **Opportunities in Contract Compliance**: There are untapped opportunities in purchased services and physician preference items, which Premier aims to address [28][29] Capital Deployment and Future Outlook - **Focus on Growth**: The company emphasizes growth through organic investments and potential acquisitions, particularly in clinical decision support and AI capabilities [57][60] - **Share Buybacks**: Premier has conducted significant share buybacks, totaling $800 million over the past 18 months, but plans to pause these to focus on growth initiatives [61][62] - **Positive Cash Flow**: The company anticipates a $100 million increase in cash flow starting in July, which will support future growth strategies [58][59] Additional Considerations - **Advisory Capabilities**: New leadership has enhanced Premier's advisory capabilities, focusing on performance improvement and revenue cycle management [42][54] - **Long-term Growth Potential**: The company is optimistic about its trajectory heading into fiscal year 2026, expecting better performance compared to the current year [53][55]
Premier (PINC) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
ZACKS· 2025-05-06 14:36
Core Insights - Premier, Inc. reported a revenue of $261.38 million for the quarter ended March 2025, reflecting a year-over-year decline of 23.7% and an EPS of $0.44 compared to $0.55 a year ago [1] - The reported revenue exceeded the Zacks Consensus Estimate of $238.88 million by 9.42%, while the EPS surprised by 41.94% against the consensus estimate of $0.31 [1] Financial Performance Metrics - Net Revenue from Supply Chain Services - Software licenses, other services, and support was $18.67 million, surpassing the average estimate of $17.41 million [4] - Net Revenue from Performance Services was $100.48 million, compared to the estimated $89.14 million, representing a year-over-year decline of 12.6% [4] - Total Net Revenue from Supply Chain Services was $160.91 million, exceeding the average estimate of $149.73 million, but showing a year-over-year decline of 29.3% [4] - Net Revenue from Supply Chain Services - Net administrative fees was $142.23 million, compared to the average estimate of $132.32 million, reflecting a year-over-year change of -9.3% [4] - Adjusted EBITDA for Supply Chain Services was $85.67 million, exceeding the estimate of $76.65 million [4] - Adjusted EBITDA for Performance Services was $19.45 million, compared to the estimated $14.26 million [4] - Adjusted EBITDA for Corporate was -$33.37 million, compared to the average estimate of -$30.96 million [4] Stock Performance - Shares of Premier have returned +7.1% over the past month, while the Zacks S&P 500 composite has changed by +11.5% [3] - The stock currently holds a Zacks Rank 2 (Buy), indicating potential outperformance against the broader market in the near term [3]
Premier(PINC) - 2025 Q3 - Earnings Call Transcript
2025-05-06 13:02
Financial Data and Key Metrics Changes - The company reported net revenue of $261 million for Q3, which grew by $21 million sequentially but declined by $25 million year-over-year due to higher fee share from contract renewals [12] - Adjusted EBITDA for Q3 was $73 million, representing a sequential improvement of $21 million and achieving the highest quarterly margin of 28.4% for the fiscal year [13] - GAAP net income from continuing operations increased by $76 million compared to the prior year period, primarily due to asset impairment charges related to Contigo Health in the previous year [12] Business Segment Data and Key Metrics Changes - The Supply Chain Services segment performed above expectations, with gross administrative fees growing driven by higher contract penetration and onboarding of new members [14] - Performance Services saw notable sequential revenue and adjusted EBITDA improvement, although consulting revenue was lower compared to the prior year, partially offset by better performance in applied sciences [16] Market Data and Key Metrics Changes - The company experienced broad growth across key categories such as med surg, diagnostics, food, and pharmacy, with gross administrative fees growing 3.5% over the prior year period [15] - The company is actively monitoring tariff developments and has seen no material disruption across its GPO portfolio, although it remains a fluid situation [6][7] Company Strategy and Development Direction - The company is committed to technology-enabled performance improvement and supply chain excellence, focusing on AI, machine learning, and automation to drive impact across various healthcare challenges [8][9] - A strategic partnership with Epic is expected to enhance the company's documentation and coding solutions, further validating its tech-forward approach [9] Management's Comments on Operating Environment and Future Outlook - Management noted that healthcare providers are under pressure due to rising costs, workforce shortages, and reimbursement challenges, leading to increased demand for the company's services [6] - The company is increasing its full-year guidance for adjusted EBITDA and adjusted EPS due to better-than-expected performance in Supply Chain Services [5][19] Other Important Information - The company initiated a $200 million accelerated share repurchase program during the quarter and returned $60 million to stockholders through dividends [5][17] - The final payment associated with the termination of the tax receivable agreement is expected by the end of the fiscal year, which will positively impact free cash flow starting July 1, 2025 [18] Q&A Session Summary Question: What is driving the outperformance in both segments? - Management indicated that the outperformance is due to a combination of factors including pressure on healthcare systems from reimbursement changes, labor shortages, and tariffs [24][25] Question: How are customers managing tariff impacts? - Management explained that healthcare systems cannot absorb significant tariffs without impacting their margins, and they are working on strategies to mitigate these costs [32][33] Question: What is the significance of pharmaceuticals in revenue? - Approximately 18.5% of gross administrative fees come from pharmaceuticals, with ongoing efforts to expand domestic drug manufacturing [66] Question: What are the expectations for health system customers in Q4? - Management expressed that health systems are under pressure and may not have a significantly positive outlook due to concerns over tariffs and labor markets [70][71] Question: Are there any one-time items in net admin fee revenue? - Management confirmed there were no one-time items in net administrative fees for the quarter, attributing the performance to effective execution [62][63]
Premier(PINC) - 2025 Q2 - Earnings Call Transcript
2025-02-04 14:00
Financial Data and Key Metrics Changes - The company reported a net revenue of $240 million for the quarter, a decrease from the prior year period, primarily due to a decline in net administrative fees revenue and supply chain services [14] - GAAP net loss from continuing operations was $46 million, mainly due to a goodwill impairment charge of $127 million related to the data and technology business in the Performance Services segment [15] - Adjusted EBITDA was $50 million, translating to a margin of 20.8%, which declined largely due to lower revenue [15] - Adjusted earnings per share was $0.25, and excluding the impact of Contigo Health, it was $0.27, in line with expectations [16] Business Line Data and Key Metrics Changes - In the Supply Chain Services segment, lower net administrative fees revenue was driven by an expected increase in the aggregate blended fee share to the low 60% level [17] - Gross administrative fees grew as existing members increased penetration of contract spend, with a growth of close to 4% overall in gross administrative fees [33] - The Performance Services segment experienced a revenue decline of 19% due to lower demand in consulting services and an unfavorable product mix in Applied Sciences [18] Market Data and Key Metrics Changes - The company is seeing a shift in member interest favoring SaaS subscription engagements versus license agreements in the Performance Services segment [19] - The company expects to address greater than 75% of the fees from the group of GPO members by the end of fiscal year 2025 [18] Company Strategy and Development Direction - The company is focused on technology enabling performance improvement and supply chain excellence for healthcare, with a strategy that includes AI enabling manual back office processes and enhancing data for actionable insights [9] - The company is committed to diversifying its supplier base to build resiliency in the supply chain and mitigate potential tariff impacts [28] - The leadership transition in the Performance Services segment aims to reinvigorate the business by recruiting new talent and refocusing solutions around key areas of differentiation [10][11] Management's Comments on Operating Environment and Future Outlook - Management remains confident in the long-term strategy despite short-term headwinds in the Performance Services segment [19] - The company is encouraged by the growing demand for provider-focused data and market intelligence, which is seen as a key differentiator in the market [10] - Management believes they are well-positioned for continued success with a flexible balance sheet and meaningful cash flow [24] Other Important Information - The company completed the sale of the network assets of Contigo Health for $15 million and is working towards divesting remaining assets [13][88] - Free cash flow for the first half of fiscal year 2025 was $74 million, an increase of $33 million from the prior year period [20] Q&A Session Summary Question: What are the discussions regarding tariffs and how are you preparing customers? - The company is focusing on building resiliency and diversification of suppliers in the supply chain to mitigate tariff impacts [28] Question: Can you provide insights on the dynamics behind net administrative fees? - The company is seeing good growth in gross administrative fees and is making progress in renegotiating contracts [32] Question: What is the expectation for the Performance Services segment in the second half of the year? - The company expects stronger performance in the second half due to a strong funnel in applied sciences and timing of enterprise license agreements [55] Question: Can you clarify the nature of the $17.6 million distribution from the minority investment? - The distribution was one-time and did not come from Omnia, and it has been adjusted out of the numbers [67] Question: How does the firm for term pricing work in relation to tariffs? - The firm for term pricing is embedded in supplier contracts, meaning suppliers absorb the tariffs, not the company or its customers [76]